RENEE BUUCK: Open Payments
NPI 1386173334 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$236 in 10 payments from 6 companies in 2025. Trend: 2023 $79 · 2024 $141 · 2025 $236
Food & beverage: $236
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $76 |
| Merck Sharp & Dohme LLC | 2 | $59 |
| Caris MPI, Inc. | 1 | $28 |
| ABBVIE INC. | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: JEMPERLI, LYNPARZA, KEYTRUDA, MI CANCER SEEK, ELAHERE, Enhertu.
Industry payments across LA — which companies pay providers there.
